---
document_datetime: 2025-09-03 15:25:10
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/omvoh-epar-all-authorised-presentations_en.pdf
document_name: omvoh-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.2718943
conversion_datetime: 2025-12-24 05:15:04.701574
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

|                                   | name        | 300 mg                   | Concentrate for solution              | Administration Intravenous use   | Packaging vial (glass)                                           | (concentration) 15 ml (20 mg/ml)         | 1 vial                                                                                         |
|-----------------------------------|-------------|--------------------------|---------------------------------------|----------------------------------|------------------------------------------------------------------|------------------------------------------|------------------------------------------------------------------------------------------------|
| EU/1/23/1736/001 EU/1/23/1736/002 | Omvoh Omvoh | 100 mg                   | for infusion Solution for injection   | Subcutaneous use                 | pre-filled syringe (glass)                                       | 1 ml (100 mg/ml)                         | 2 pre-filled syringes                                                                          |
| EU/1/23/1736/003                  | Omvoh       | 100 mg                   | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass)                                       | 1 ml (100 mg/ml)                         | 6 (3 x 2) pre-filled syringes                                                                  |
| EU/1/23/1736/004                  | Omvoh       | 100 mg                   | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass) in pre-                               | 1 ml (100 mg/ml)                         | (multipack) 2 pre-filled pens                                                                  |
|                                   |             |                          |                                       |                                  | filled pen pre-filled                                            |                                          |                                                                                                |
| EU/1/23/1736/005                  | Omvoh       | 100 mg                   | Solution for injection                | Subcutaneous use                 | syringe (glass) in pre- filled pen                               | 1 ml (100 mg/ml)                         | 4 (2 x 2) pre-filled pens (multipack)                                                          |
| EU/1/23/1736/006                  | Omvoh       | 100 mg                   | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass) in pre- filled pen                    | 1 ml (100 mg/ml)                         | 6 (3 x 2) pre-filled pens (multipack)                                                          |
| EU/1/23/1736/007                  | Omvoh       | 100 mg + 200 mg          | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass)                                       | 1 ml + 2 ml (100 mg/ml)                  | 1 pre-filled syringe of 100 mg + 1 pre- filled syringe of 200 mg                               |
| EU/1/23/1736/008                  | Omvoh       | 100 mg + 200 mg          | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass)                                       | 1 ml + 2 ml (100 mg/ml)                  | 3 (3 x 1) pre-filled syringes of 100 mg + 3 (3 x 1) pre- filled syringes of 200 mg (multipack) |
| EU/1/23/1736/009 EU/1/23/1736/010 | Omvoh Omvoh | 100 mg + 200 mg 100 mg + | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass) in pre- filled pen pre-filled syringe | 1 ml + 2 ml (100 mg/ml) 1 ml + 2 ml (100 | 1 pre-filled pen of 100 mg + 1 pre- filled pen of 200 mg                                       |
|                                   | Omvoh       | 200 mg 300 mg            | Solution for injection                | Subcutaneous use                 | (glass) in pre- filled pen                                       | mg/ml) 15 ml (20 mg/ml)                  | 3 (3 x 1) pre-filled pens of 100 mg + 3 (3 x 1) pre-filled pens of 200 mg (multipack)          |
| EU/1/23/1736/011                  |             |                          | Concentrate for solution for infusion | Intravenous use                  | vial (glass)                                                     |                                          | 3 (3 x 1) vials (multipack)                                                                    |
| EU/1/23/1736/012                  | Omvoh       | 200 mg                   | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass)                                       | 2 ml (100 mg/ml)                         | 1 pre-filled syringe                                                                           |
| EU/1/23/1736/013                  | Omvoh       | 200 mg                   | Solution for injection                | Subcutaneous use                 | pre-filled syringe (glass)                                       | 2 ml (100 mg/ml)                         | 3 (3 x 1) pre-filled syringes (multipack)                                                      |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size                             |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------------------|---------------------------|---------------------------------------|
| EU/1/23/1736/014 | Omvoh             | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 2 ml (100 mg/ml)          | 1 pre-filled pen                      |
| EU/1/23/1736/015 | Omvoh             | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 2 ml (100 mg/ml)          | 3 (3 x 1) pre-filled pens (multipack) |